IONS insider Joseph Baroldi to sell 4,096 shares

Joseph Baroldi filed a Form 144 to sell Common Stock.

Rhea-AI Filing Summary

Joseph Baroldi filed a Form 144 to sell Common Stock. The filing lists 4,096 shares of Common Stock tied to Restricted Stock Units (grant date 01/15/2022) and identifies Stifel Nicolaus & Company Inc. as the broker for the proposed sale dated 03/03/2026. The filing also shows recent dispositions, including sales of 5,296 shares on 01/30/2026 and 6,999 shares on 01/16/2026, with associated aggregate amounts listed in the excerpt.

Insights

Equity Securities Counsel

Form 144 notifies the broker and SEC of a proposed resale of insider-held shares.

Form 144 identifies 4,096 shares linked to Restricted Stock Units (grant date 01/15/2022) and names Stifel Nicolaus & Company Inc. as the broker. The filing date shown is 03/03/2026.

Prior dispositions are listed as examples, including 5,296 shares (sold 01/30/2026) and 6,999 shares (sold 01/16/2026); the excerpt shows aggregate dollar entries alongside those dates. The filing documents the proposed method and recent activity; cash‑flow treatment and further sale mechanics are not detailed in the provided excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Joseph Baroldi's Form 144 for IONS report?

It reports a proposed sale of 4,096 shares of Common Stock tied to RSUs. The filing names Stifel Nicolaus & Company Inc. as broker and carries a filing date of 03/03/2026, with recent prior dispositions also listed.

How many shares are listed as securities to be sold in the filing?

The filing lists 4,096 shares as the securities to be sold. These are shown as Restricted Stock Units with a grant date of 01/15/2022 and are associated with equity compensation in the excerpt.

Does the Form 144 show any recent sales by Baroldi?

Yes; the filing shows recent dispositions of 5,296 and 6,999 shares. Those sales are dated 01/30/2026 and 01/16/2026, respectively, with aggregate dollar figures included in the excerpt.

Which broker is handling the proposed sale on the Form 144?

Stifel Nicolaus & Company Inc. is listed as the broker, with an address of 501 N Broadway, St. Louis, MO. The filing associates the broker with the proposed resale activity dated 03/03/2026.

Are the proceeds or detailed sale mechanics disclosed in the excerpt?

Specific proceeds use and detailed sale mechanics are not described in the excerpt. The filing displays aggregate dollar amounts beside recent dispositions but does not provide further allocation or method details in the provided content.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 05:42 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001813775
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IONIS PHARMACEUTICALS INC
SEC File Number	000-19125
Address of Issuer	2855 GAZELLE COURT CARLSBAD CALIFORNIA 92010
Phone	7609319200
Name of Person for Whose Account the Securities are To Be Sold	Baroldi Joseph
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	4096	325059.00	161970000	03/03/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/15/2022	Restricted Stock Units	Issuer			4096	01/15/2022	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Joseph Baroldi 2855 GAZELLE COURT CARLSBAD CA 92010	Common Stock	01/30/2026	5296	439694.00
Joseph Baroldi 2855 GAZELLE COURT CARLSBAD CA 92010	Common Stock	01/16/2026	6999	439694.00

144: Remarks and Signature

Remarks
Date of Notice	03/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/24/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Luca Lotito, as a duly authorized representative of STIFEL, as attorney-in-fact for Joseph Baroldi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)